Review of health safety aspects of nanotechnologies in food production

Regulatory Toxicology and Pharmacology

Volumn 53, Issue 1, 2009, Pages 52-62

  Bouwmeester, Hans ^a   Dekkers, Susan ^b   Noordam, Maryvon Y ^a   Hagens, Werner I ^b   Bulder, Astrid S ^a   de Heer, Cees ^b   ten Voorde, Sandra E C G ^a   Wijnhoven, Susan W P ^b   Marvin, Hans J P ^a   Sips, Adriënne J A M ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Detection; Exposure; Food; Kinetics; Nanoparticles; Nanotechnology; Oral; Risk assessment; Toxicology

Indexed keywords

COPPER; LIPOSOME; METAL; METAL OXIDE; NANOLIPOSOME; NANOPARTICLE; POLYMER; SILVER; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; ZINC OXIDE;

ACUTE TOXICITY; ALLERGENICITY; ARTICLE; CHRONIC TOXICITY; CONSUMER HEALTH INFORMATION; DRUG DELIVERY SYSTEM; FOOD INDUSTRY; FOOD SAFETY; FOOD SECURITY; GASTROINTESTINAL ABSORPTION; HEALTH CARE POLICY; HUMAN; MICELLIZATION; MICROORGANISM DETECTION; NANOEMULSION; NANOENCAPSULATION; NANOTECHNOLOGY; PACKAGING MATERIAL; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICITY TESTING; TOXICOKINETICS;

CONSUMER PRODUCT SAFETY; FOOD; FOOD ADDITIVES; FOOD ANALYSIS; FOOD INDUSTRY; FOOD PACKAGING; HUMANS; LEGISLATION, FOOD; NANOPARTICLES; NANOTECHNOLOGY; RISK ASSESSMENT;

EID: 59049101808     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.10.008     Document Type: Article

References (87)

1. Aprahamian M., Michel C., Humbert W., Devissaguet J.P., and Damge C. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small-intestine. Biology of the Cell 61 1-2 (1987) 69-76
2. Avella M., De Vlieger J.J., Errico M.E., Fischer S., Vacca P., and Volpe M.G. Biodegradable starch/clay nanocomposite films for food packaging applications. Food Chemistry 93 3 (2005) 467-474
3. Balbus J.M., Maynard A.D., Colvin V.L., Castranova V., Daston G.P., Denison R.A., Dreher K.L., Goering P.L., Goldberg A.M., Kulinowski K.M., et al. Meeting report: hazard assessment for nanoparticles-report from an interdisciplinary workshop. Environ. Health Perspect. 115 11 (2007) 1654-1659
4. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., and Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15 1 (2004) 79-86
5. Borm P., Klaessig F.C., Landry T.D., Moudgil B., Pauluhn J., Thomas K., Trottier R., and Wood S. Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. Toxicol. Sci. 90 1 (2006) 23-32
6. Borm P.J.A., and Kreyling W. Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. Journal of Nanoscience and Nanotechnology 4 5 (2004) 521-531
7. Carr K.E., Hazzard R.A., Reid S., and Hodges G.M. The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm. Res. 13 8 (1996) 1205-1209
8. Chau C.-F., Wu S.-H., and Yen G.-C. The development of regulations for food nanotechnology. Trends in Food Science and Technology 18 5 (2007) 269-280
9. Chaudhry Q., George C., and Watkins R. Nanotechnology Regulation-evelopments in the United Kingdom. In: Hodge G.A., Bowman D.M., and Ludlow K. (Eds). New Global Frontiers in Regulation: The Age of Nanotechnology (2007), Edward Elgar, Cheltenham 212-238
10. Chaudhry Q., Scotter M., Blackburn J., Ross B., Boxall A., Castle L., Aitken R., and Watkins R. Applications and implications of nanotechnologies for the food sector. Food Addit. Contam. 25 3 (2008) 241-258
11. Chen H.D., Weiss J.C., and Shahidi F. Nanotechnology in nutraceuticals and functional foods. Food Technology 60 3 (2006) 30
12. Chen L.Y., Remondetto G.E., and Subirade M. Food protein-based materials as nutraceutical delivery systems. Trends in Food Science and Technology 17 5 (2006) 272-283
13. Chen Z., Meng H., Xing G., Chen C., Zhao Y., Jia G., Wang T., Yuan H., Ye C., Zhao F., et al. Acute toxicological effects of copper nanoparticles in vivo. Toxicol. Lett. 163 2 (2006) 109-120
14. Coyle P., Philcox J.C., Carey L.C., and Rofe A.M. Metallothionein: the multipurpose protein. Cellular and Molecular Life Sciences 59 4 (2002) 627-647
15. De Jong W.H., Hagens W.I., Krystek P., Burger M.C., Sips A.J., and Geertsma R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29 12 (2008) 1912-1919
16. des Rieux A., Fievez V., Garinot M., Schneider Y.J., and Preat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Control. Release 116 1 (2006) 1-27
17. Dinsmore A. Colloidosomes: Selectively permeable capsules composed of colloidal particles. Science 298 5595 (2002) 1006-1009
18. Dobrovolskaia M. Immunological properties of engineered nanomaterials. Nature nanotechnology 2 8 (2007) 469-478
19. Donaldson K., Faus S., Borm P.J.A., and Stone V. Approaches to the toxicological testing of particles. In: Donaldson K., and Borm P.J.A. (Eds). Particle Toxicology (2007), CRC press Taylor and Francis group, London 299-316
20. Donaldson K., and Seaton A. The Janus faces of nanoparticles. J. Nanosci. Nanotechnol. 7 12 (2007) 4607-4611
21. Donaldson K., Stone V., Clouter A., Renwick L., and MacNee W. Ultrafine particles. Occup. Environ. Med. 58 3 (2001) 211-216 199
22. Communication from the Commission-Towards a European strategy for nanotechnology, 2004. Luxembourg: Office for Official Publications of the European Communities 2004, pp. 24 ISBN 92-894-7686-9 (17.6 × 25 cm).
23. FAO/WHO, 1997. Food consumption and exposure assessment of chemicals, Report of a FAO/WHO Consultation, 10-14 February 1997, Geneva, Document WHO/FSF/FOS/97.5, WHO, Geneva.
24. Florence A.T. Nanoparticle uptake by the oral route: Fulfilling its potential?. Drug Discovery Today: Technologies 2 1 (2005) 75-81
25. Fujimoto A., Tsukue N., Watanabe M., Sugawara I., Yanagisawa R., Takano H., Yoshida S., and Takeda K. Diesel exhaust affects immunological action in the placentas of mice. Environ. Toxicol. 20 4 (2005) 431-4340
26. Gabor F., Bogner E., Weissenboeck A., and Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv. Drug Deliv. Rev. 56 4 (2004) 459-480
27. Gergely A. Regulation of nanotechnology-within REACH?. Nano Now February (2007) 44-46
28. Geiser M., Rothen-Rutishauser B., Kapp N., Schurch S., Kreyling W., Schulz H., Semmler M., Im Hof V., Heyder J., and Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113 11 (2005) 1555-1560
29. Govers M., Termont D., Vanaken G.A., and Vandermeer R. Characterization of the adsorption of conjugated and unconjugated bile-acids to insoluble, amorphous calcium-phosphate. Journal of Lipid Research 35 5 (1994) 741-748
30. Graveland-Bikker J.F., and de Kruif C.G. Unique milk protein based nanotubes: Food and nanotechnology meet. Trends in Food Science and Technology 17 5 (2006) 196-203
31. Hagens W.I., Oomen A.G., de Jong W.H., Cassee F.R., and Sips A.J. What do we (need to) know about the kinetic properties of nanoparticles in the body?. Regul. Toxicol. Pharmacol. 49 3 (2007) 217-229
32. Hardman R. A toxicologic review of quantum dots: toxicity depends on physico-chemical and environmental factors. Environ Health Perspect 114 2 (2006) 165-172
33. Health Council Netherlands. 2006. Health significance of nanotechnologies. The Hague: Health Council of the Netherlands, Publication No. 2006/06.
34. Hentschel A., Gramdorf S., Muller R.H., and Kurz T. beta-Carotene-loaded nanostructured lipid carriers. Journal of Food Science 73 2 (2008) N1-N6
35. Hillery A.M., Jani P.U., and Florence A.T. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J. Drug Target. 2 2 (1994) 151-156
36. Hillyer J.F., and Albrecht R.M. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. Journal of Pharmaceutical Sciences 90 12 (2001) 1927-1936
37. Hodge, G., Bowman, D., Ludlow, K., 2007. New Global Frontiers in Regulation: In: The Age of Nanotechnology. Edward Elgar, Cheltenham.
38. Hoet P., Bruske-Hohlfeld I., and Salata O. Nanoparticles - known and unknown health risks. Journal of Nanobiotechnology 2 1 (2004) 12
39. Hong S.P., Leroueil P.R., Janus E.K., Peters J.L., Kober M.M., Islam M.T., Orr B.G., Baker J.R., and Holl M.M.B. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjugate Chemistry 17 3 (2006) 728-734
40. Hsieh Y.F., Chen T.L., Wang Y.T., Chang J.H., and Chang H.M. Properties of liposomes prepared with various lipids. Journal of Food Science 67 8 (2002) 2808-2813
41. Jani P., Halbert G.W., Langridge J., and Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42 12 (1990) 821-826
42. Jia X., Li N., and Chen J. A subchronic toxicity study of elemental Nano-Se in Sprague-Dawley rats. Life Sci. 76 17 (2005) 1989-2003
43. Kabanov A.V. Polymer genomics: An insight into pharmacology and toxicology of nanomedicines. Advanced Drug Delivery Reviews 58 15 (2006) 1597-1621
44. Kroes R., Muller D., Lambe J., Lowik M.R.H., van Klaveren J., Kleiner J., Massey R., Mayer S., Urieta I., and Verger P. Assessment of intake from the diet. Food and Chemical Toxicology 40 2-3 (2002) 327-385
45. Langer R. Advances in biomaterials, drug delivery, and bionanotechnology. American Institute of Chemical Engineers. AIChE Journal 49 12 (2003) 2990-3006
46. Laridi R., Kheadr E.E., Benech R.O., Vuillemard J.C., Lacroix C., and Fliss I. Liposome encapsulated nisin Z: optimization, stability and release during milk fermentation. International Dairy Journal 13 4 (2003) 325-336
47. Letchford K., and Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur. J. Pharm. Biopharm. 65 3 (2007) 259-269
48. Lewinski N., Colvin V., and Drezek R. Cytotoxicity of nanoparticles. Small 4 1 (2008) 26-49
49. Lomer M.C., Thompson R.P., and Powell J.J. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc. Nutr. Soc. 61 1 (2002) 123-130
50. Luykx, D., Peters, R., Ruth van, S., Bouwmeester, H., 2008. A review of analytical methods for the identification and characterisation of nano delivery systems in food. Journal of Agricultural and Food Chemistry, ASAP Article, 10.1021/jf8013926.
51. Maynard A.D., Aitken R.J., Butz T., Colvin V., Donaldson K., Oberdorster G., Philbert M.A., Ryan J., Seaton A., Stone V., et al. Safe handling of nanotechnology. Nature 444 7117 (2006) 267-269
52. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., and Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 150 5 (2007) 552-558
53. Morgan K. Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles. Risk Anal. 25 6 (2005) 1621-1635
54. Mozafari M.R., Flanagan J., Matia-Merino L., Awati A., Omri A., Suntres Z.E., and Singh H. Recent trends in the lipid-based nanoencapsulation of antioxidants and their role in foods. Journal of the Science of Food and Agriculture 86 13 (2006) 2038-2045
55. Nel A., Xia T., Madler L., and Li N. Toxic potential of materials at the nanolevel. Science 311 5761 (2006) 622-627
56. Nemmar A., Hoet P.H.M., Vanquickenborne B., Dinsdale D., Thomeer M., Hoylaerts M.F., Vanbilloen H., Mortelmans L., and Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation 105 4 (2002) 411-414
57. Oberdorster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., Ausman, K., Carter, J., Karn, B., Kreyling, W., Lai, D., 2005a. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Particle and Fibre Toxicology 2, 8
58. Oberdorster G., Oberdorster E., and Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113 7 (2005) 823-839
59. Oberdorster G., Oberdorster E., and Oberdorster J. Concepts of nanoparticle dose metric and response metric. Environ Health Perspect 115 6 (2007) A290
60. Oberdorster G., Stone V., and Donaldson K. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1 1 (2007) 2-25
61. Ogawara K., Yoshida M., Higaki K., Kimura T., Shiraishi K., Nishikawa M., Takakura Y., and Hashida M. Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. J. Control. Release 59 1 (1999) 15-22
62. Patel G. In vitro assessment of archaeosome stability for developing oral delivery systems. International Journal of Pharmaceutics 194 1 (2000) 39-49
63. Powers K.W., Brown S.C., Krishna V.B., Wasdo S.C., Moudgil B.M., and Roberts S.M. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 90 2 (2006) 296-303
64. Powers K.W., Moudgil B.M., and Roberts S.M. Characterization of the size, shape and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 1 1 (2007) 42-51
65. Roszek B., de Jong W., and Geertsma R. Nanotechnology in medical applications: State-of-the-art in materials and devices. RIVM report (2005) 265001001/2005
66. Rothen-Rutishauser B.M., Schurch S., Haenni B., Kapp N., and Gehr P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Technol. 40 14 (2006) 4353-4359
67. Russell-Jones G.J., Veitch H., and Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int. J. Pharm. 190 2 (1999) 165-174
68. Salamat-Miller N., and Johnston T.P. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. International Journal of Pharmaceutics 294 1-2 (2005) 201-216
69. SCENIHR, 2007a. Scientific Committee on Emerging and Newly Identified Health Risk SCENIHR. Opinion on: the appropriateness of the risk assessment methodology in accordance with the technical guidance documents for new and existing substances for assessing the risks of nanomaterials European Commission Health and Consumer Protection Directorate-General. Directorate C-Public Health and Risk Assesment C7-Risk Assessment.
70. SCENIHR, 2007b. Scientific Committee on Emerging and Newly Identified Health Risk SCENIHR. Opinion on : the scientific aspects of the existing and proposed definitions relating to products of nanoscience and nanotechnologies European Commission Health and Consumer Protection Directorate-General. Directorate C-Public Health and Risk Assessment C7-Risk Assessment.
71. Silva G.A. Nanotechnology approaches for drug and small molecule delivery across the blood-brain barrier. Surgical Neurology 67 2 (2007) 113-116
72. Singh R., Pantarotto D., Lacerda L., Pastorin G., Klumpp C., Prato M., Bianco A., and Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. USA 103 9 (2006) 3357-3362
73. Szentkuti L. Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon. Journal of Controlled Release 46 3 (1997) 233-242
74. Taylor T.M., Davidson P.M., Bruce B.D., and Weiss J. Liposomal nanocapsules in food science and agriculture. Crit. Rev. Food Sci. Nutr. 45 7-8 (2005) 587-605
75. The Royal Society and the Royal Academy of Engineering, 2004. The Royal Society and the Royal Academy of Engineering. Nanoscience and nanotechnologies: opportunities and uncertainties. London, UK.
76. Thomas K., and Sayre P. Research strategies for safety evaluation of nanomaterials, part I: evaluating the human health implications of exposure to nanoscale materials. Toxicol. Sci. 87 2 (2005) 316-321
77. Tiede K., Boxall A.B., Tear S.P., Lewis J., David H., and Hassellov M. Detection and characterization of engineered nanoparticles in food and the environment. Food Addit. Contam. 25 7 (2008) 795-821
78. Tran, C.L., Danaldson, K., Stones, V., Fernandez, T., Ford, A., Christofi, N., Ayres, J.G., Steiner, M., Hurley, J.F., Aitken, R.J. et al., 2005. A scoping study to identify hazard data needs for addressing risks presented by nanoparticles and nanotubes. Institute of Occupational Medicine (IOM) Research Report, Edinburgh, United Kingdom.
79. Wang B., Feng W.Y., Wang M., Wang T.C., Gu Y.Q., Zhu M.T., Ouyang H., Shi J.W., Zhang F., and Zhao Y.L. Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice. Journal of Nanoparticle Research 10 2 (2008) 263-276
80. Wang B., Feng W.Y., Wang T.C., Jia G., Wang M., Shi J.W., Zhang F., Zhao Y.L., and Chai Z.F. Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. Toxicol. Lett. 161 2 (2006) 115-123
81. Wang J., Zhou G., Chen C., Yu H., Wang T., Ma Y., Jia G., Gao Y., Li B., and Sun J. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 168 2 (2007) 176-185
82. Weiss J., Takhistov P., and McClements J. Functional materials in food nanotechnology. Journal of Food Science 71 9 (2006) R107-R116
83. Were L.M., Bruce B.D., Davidson P.M., and Weiss J. Size, stability, and entrapment efficiency of phospholipid nanocapsules containing polypeptide antimicrobials. Journal of Agricultural and Food Chemistry 51 27 (2003) 8073-8079
84. Woodrow Wilson International Center for Scholars. Assuring the safety of nanomaterials in food packaging: the regulatory process and key issues. Available from: (accessed 28.08.2008).
85. Zarif L. Nanocochleate cylinders for oral & parenteral delivery of drugs. Journal of liposome research 13 1 (2003) 109-110
86. Zhang J., Wang H., Yan X., and Zhang L. Comparison of short-term toxicity between Nano-Se and selenite in mice. Life Sci. 76 10 (2005) 1099-1109
87. Zwiorek K., Kloeckner J., Wagner E., and Coester C. Gelatine nanoparticles as a new and simple gene delivery system. Journal of Pharmacological and Pharmaceutical science 7 4 (2004) 22-28